Position in SGMOQ
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$3,377
+$3,315 QoQ
Shares Held
13,509
+266.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMOQ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IFP Advisors, Inc holds $55,990,065 across 216 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
62,273 | $15,242,562 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
209,318 | $11,499,930 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
34,193 | $8,239,487 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
361,634 | $6,136,928 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
61,616 | $2,403,640 | |
| 6 | EXEL |
Exelixis, Inc.
|
43,101 | $2,345,125 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,968 | $1,474,294 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,352 | $843,026 |
All Filings in SGMOQ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,377 | 13,509 | Shares | Sole | 2026-04-13 | |
| 2022-12-31 | $62 | 3,688 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $20,080 | 4,098 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $16,965 | 4,098 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $23,809 | 4,098 | Shares | Sole | 2022-09-06 | |
| 2021-06-30 | $2,465 | 206 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $3,132 | 250 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $4,199 | 269 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,927 | 204 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,397 | 156 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $993 | 156 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||